variant Creutzfeldt-Jakob Disease (vCJD)
Inquiry by the Science and Technology Committee (Commons), 19 November 2013 to 3 December 2013. Its page on the Parliament website.
Evidence sessions
- 27 November 2013: Professor James Ironside, Professor of Clinical Neuropathology, National CJD Research and Surveillance Unit, University of Edinburgh, Dr Roland Salmon, Joint Chair, Advisory Committee on Dangerous Pathogens TSE Sub Group, and Professor John Collinge, Professor of Neurology, UCL Institute of Neurology and Director of the MRC Prion Unit.